hydrogen sulfide has been researched along with Diabetes Mellitus in 32 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sensitive detection of acetone and hydrogen sulfide levels in exhaled human breath, serving as breath markers for some diseases such as diabetes and halitosis, may offer useful information for early diagnosis of these diseases." | 7.80 | Selective detection of acetone and hydrogen sulfide for the diagnosis of diabetes and halitosis using SnO(2) nanofibers functionalized with reduced graphene oxide nanosheets. ( Choi, SJ; Jang, BH; Kim, ID; Lee, SJ; Min, BK; Rothschild, A, 2014) |
| "Hydrogen sulfide (H2S)has emerged as the third gasotransmitter following the nitric oxide and carbon monoxide in the body, and plays an important role in both physiology and pathophysiology." | 6.58 | [Research Advances in Hydrogen Sulfide and Diabetes Mellitus as Well as Diabetic Complications]. ( Gu, Y; Ji, Y; Meng, GL; Xie, LP, 2018) |
| "Hydrogen sulfide (H2S) has been shown to have powerful antioxidative and anti-inflammatory properties that can regulate multiple cardiovascular functions." | 5.43 | Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation. ( Ferro, A; Gu, Y; Han, Y; Huang, Z; Ji, Y; Liu, G; Ma, Y; Meng, G; Moore, PK; Wang, H; Wang, W; Wang, X; Wang, Y; Wen, M; Xie, L; Yu, Y; Zhang, Z; Zhao, S, 2016) |
| "DNA-based sensors can detect disease biomarkers, including acetone and ethanol for diabetes and H2S for cardiovascular diseases." | 3.83 | Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics. ( Cranford, SW; Wang, ML; Zhang, W, 2016) |
| "Sensitive detection of acetone and hydrogen sulfide levels in exhaled human breath, serving as breath markers for some diseases such as diabetes and halitosis, may offer useful information for early diagnosis of these diseases." | 3.80 | Selective detection of acetone and hydrogen sulfide for the diagnosis of diabetes and halitosis using SnO(2) nanofibers functionalized with reduced graphene oxide nanosheets. ( Choi, SJ; Jang, BH; Kim, ID; Lee, SJ; Min, BK; Rothschild, A, 2014) |
| " Here, we report ultrafast as well as highly sensitive bumpy WO3 hemitube nanostructure assisted by O2 plasma surface modification with functionalization of graphene-based material for the detection of acetone (CH3COCH3) and hydrogen sulfide (H2S) which are biomarkers for the diagnosis of diabetes and halitosis, respectively." | 3.80 | Fast responding exhaled-breath sensors using WO3 hemitubes functionalized by graphene-based electronic sensitizers for diagnosis of diseases. ( Choi, SJ; Demadrille, R; Fuchs, F; Grévin, B; Jang, BH; Kim, ID; Lee, JH; Lee, SJ; Tuller, HL, 2014) |
| "Hydrogen sulfide (H2S)has emerged as the third gasotransmitter following the nitric oxide and carbon monoxide in the body, and plays an important role in both physiology and pathophysiology." | 2.58 | [Research Advances in Hydrogen Sulfide and Diabetes Mellitus as Well as Diabetic Complications]. ( Gu, Y; Ji, Y; Meng, GL; Xie, LP, 2018) |
| "Hydrogen sulfide (H2S) is a biologically active gas that is synthesized naturally by three enzymes, cystathionine γ-lyase (CSE), cystathionine β-synthetase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST)." | 2.52 | H2S Synthesizing Enzymes: Biochemistry and Molecular Aspects. ( Huang, CW; Moore, PK, 2015) |
| "Hydrogen sulfide (H2S) is a gasotransmitter that regulates numerous physiological and pathophysiological processes in our body." | 2.50 | Hydrogen sulfide and the liver. ( Cao, W; Mani, S; Wang, R; Wu, L, 2014) |
| " In patients with diabetes, a lower bioavailability of the different gasotransmitters is observed when compared with healthy individuals." | 1.43 | Gasotransmitters in Vascular Complications of Diabetes. ( Greffrath, W; Hammes, HP; Hillebrands, JL; van den Born, JC; van Goor, H, 2016) |
| "Hydrogen sulfide (H2S) has been shown to have powerful antioxidative and anti-inflammatory properties that can regulate multiple cardiovascular functions." | 1.43 | Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation. ( Ferro, A; Gu, Y; Han, Y; Huang, Z; Ji, Y; Liu, G; Ma, Y; Meng, G; Moore, PK; Wang, H; Wang, W; Wang, X; Wang, Y; Wen, M; Xie, L; Yu, Y; Zhang, Z; Zhao, S, 2016) |
| "Hydrogen sulfide (H(2)S) has recently been found to play beneficial roles in ameliorating several diseases, including hypertension, atherosclerosis and cardiac/renal ischemia-reperfusion injuries." | 1.39 | Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy. ( Imai, E; Kimura, T; Kojima, H; Kosugi, T; Maruyama, S; Matsuo, S; Niki, I; Sato, W; Taniguchi, S; Yamamoto, J; Yamamoto, T; Yuzawa, Y, 2013) |
| "Hydrogen sulfide (H(2)S) is an important signaling molecule in various mammalian cells and tissues." | 1.37 | Significance of hydrogen sulfide production in the pancreatic β-cell. ( Niki, I; Taniguchi, S, 2011) |
| "Hydrogen sulfide (H(2)S) has been traditionally known for its toxic effects on living organisms." | 1.35 | Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. ( Cao, K; Duridanova, D; Jia, X; Wang, R; Wu, L; Yang, G; Yang, W, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 19 (59.38) | 24.3611 |
| 2020's | 10 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Carbone, F | 1 |
| Montecucco, F | 1 |
| Zhao, H | 1 |
| Liu, H | 3 |
| Yang, Y | 1 |
| Lan, T | 1 |
| Wang, H | 4 |
| Wu, D | 1 |
| Inada, R | 1 |
| Mendoza, HY | 1 |
| Tanaka, T | 1 |
| Horie, T | 1 |
| Satomi, T | 1 |
| Sun, HJ | 1 |
| Xiong, SP | 1 |
| Wang, ZC | 1 |
| Nie, XW | 1 |
| Bian, JS | 1 |
| Ge, Y | 1 |
| Rong, F | 1 |
| Lu, Y | 1 |
| Wang, Z | 1 |
| Liu, J | 1 |
| Xu, F | 1 |
| Chen, J | 1 |
| Li, W | 1 |
| Wang, Y | 2 |
| Bushell, CJ | 1 |
| Forgan, LG | 1 |
| Aston-Mourney, K | 1 |
| Connor, T | 1 |
| McGee, SL | 1 |
| McNeill, BA | 1 |
| Liu, X | 1 |
| Han, X | 1 |
| Shang, Y | 1 |
| Wang, L | 1 |
| Shen, J | 1 |
| Yuan, J | 1 |
| Kang, SC | 1 |
| Sohn, EH | 1 |
| Lee, SR | 1 |
| Shi, X | 1 |
| Qiu, M | 1 |
| Lv, S | 2 |
| Zheng, H | 1 |
| Niu, B | 1 |
| Sandu, RE | 1 |
| Dumbrava, D | 1 |
| Surugiu, R | 1 |
| Glavan, DG | 1 |
| Gresita, A | 1 |
| Petcu, EB | 1 |
| Kashfi, K | 1 |
| Gu, Y | 2 |
| Xie, LP | 1 |
| Meng, GL | 1 |
| Ji, Y | 2 |
| Okamoto, M | 1 |
| Yamaoka, M | 1 |
| Kimura, T | 2 |
| Choi, SJ | 2 |
| Jang, BH | 2 |
| Lee, SJ | 2 |
| Min, BK | 1 |
| Rothschild, A | 1 |
| Kim, ID | 2 |
| Mani, S | 1 |
| Cao, W | 1 |
| Wu, L | 3 |
| Wang, R | 3 |
| Song, P | 1 |
| Zou, MH | 1 |
| Fuchs, F | 1 |
| Demadrille, R | 1 |
| Grévin, B | 1 |
| Lee, JH | 1 |
| Tuller, HL | 1 |
| Coletta, C | 1 |
| Módis, K | 1 |
| Szczesny, B | 1 |
| Brunyánszki, A | 1 |
| Oláh, G | 1 |
| Rios, EC | 1 |
| Yanagi, K | 1 |
| Ahmad, A | 1 |
| Papapetropoulos, A | 1 |
| Szabo, C | 2 |
| Huang, CW | 1 |
| Moore, PK | 2 |
| Zhang, W | 1 |
| Wang, ML | 1 |
| Cranford, SW | 1 |
| van den Born, JC | 1 |
| Hammes, HP | 1 |
| Greffrath, W | 1 |
| van Goor, H | 1 |
| Hillebrands, JL | 1 |
| Xie, L | 1 |
| Wen, M | 1 |
| Zhao, S | 1 |
| Wang, W | 1 |
| Ma, Y | 1 |
| Meng, G | 1 |
| Han, Y | 1 |
| Liu, G | 1 |
| Wang, X | 1 |
| Zhang, Z | 1 |
| Yu, Y | 1 |
| Ferro, A | 1 |
| Huang, Z | 1 |
| Gerő, D | 1 |
| Torregrossa, R | 1 |
| Perry, A | 1 |
| Waters, A | 1 |
| Le-Trionnaire, S | 1 |
| Whatmore, JL | 1 |
| Wood, M | 1 |
| Whiteman, M | 1 |
| Durante, W | 1 |
| Yang, W | 2 |
| Jia, X | 1 |
| Yang, G | 2 |
| Duridanova, D | 1 |
| Cao, K | 1 |
| Du, JB | 1 |
| Tang, CS | 1 |
| Taniguchi, S | 2 |
| Niki, I | 3 |
| Yamamoto, J | 1 |
| Sato, W | 1 |
| Kosugi, T | 1 |
| Yamamoto, T | 1 |
| Kojima, H | 1 |
| Maruyama, S | 1 |
| Imai, E | 1 |
| Matsuo, S | 1 |
| Yuzawa, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short-Term Endogenous Hydrogen Sulfide Upregulation For Vein Graft Disease[NCT05457881] | 226 participants (Anticipated) | Interventional | 2024-03-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for hydrogen sulfide and Diabetes Mellitus
| Article | Year |
|---|---|
Hydrogen Sulfide Plays an Important Role by Regulating Endoplasmic Reticulum Stress in Diabetes-Related Diseases.
Topics: Diabetes Mellitus; Diabetic Cardiomyopathies; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; H | 2022 |
Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions.
Topics: Diabetes Complications; Diabetes Mellitus; Humans; Hydrogen Sulfide; Liver | 2023 |
Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis.
Topics: Animals; Cardiomyopathies; Diabetes Mellitus; Fibrosis; Humans; Hydrogen Sulfide; Hypertension; Myoc | 2020 |
Hydrogen Sulfide Plays an Important Role by Influencing NLRP3 inflammasome.
Topics: Animals; Diabetes Mellitus; Humans; Hydrogen Sulfide; Inflammasomes; Macrophages; Neuroprotection; N | 2020 |
Exogenous Hydrogen Sulfide Plays an Important Role by Regulating Autophagy in Diabetic-Related Diseases.
Topics: Animals; Autophagy; Depressive Disorder; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Cardiomy | 2021 |
Cellular and Molecular Mechanisms Underlying Non-Pharmaceutical Ischemic Stroke Therapy in Aged Subjects.
Topics: Animals; Brain Ischemia; Caloric Restriction; Comorbidity; Diabetes Mellitus; Diet, High-Fat; Diseas | 2017 |
[Research Advances in Hydrogen Sulfide and Diabetes Mellitus as Well as Diabetic Complications].
Topics: Carbon Monoxide; Diabetes Complications; Diabetes Mellitus; Humans; Hydrogen Sulfide; Nitric Oxide | 2018 |
[Hydrogen sulfide and its effect on pancreatic beta-cells].
Topics: Animals; Cell Survival; Diabetes Mellitus; Humans; Hydrogen Sulfide; Insulin; Insulin-Secreting Cell | 2013 |
Hydrogen sulfide and the liver.
Topics: Animals; Diabetes Mellitus; Glucose; Humans; Hydrogen Sulfide; Lipid Metabolism; Liver; Liver Diseas | 2014 |
H2S Synthesizing Enzymes: Biochemistry and Molecular Aspects.
Topics: Animals; Asthma; Atherosclerosis; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes M | 2015 |
Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications.
Topics: Animals; Diabetes Complications; Diabetes Mellitus; Humans; Hydrogen Sulfide | 2012 |
21 other studies available for hydrogen sulfide and Diabetes Mellitus
| Article | Year |
|---|---|
Hydrogen sulphide: Diabetic cardiomyopathy as the paradigm of its pleiotropic function.
Topics: Diabetes Mellitus; Diabetic Cardiomyopathies; Humans; Hydrogen Sulfide | 2022 |
Preclinical study for the treatment of diabetes mellitus using β-like cells derived from human dental pulp stem cells.
Topics: Animals; Dental Pulp; Diabetes Mellitus; Humans; Hydrogen Sulfide; Insulins; Rats; Stem Cells | 2022 |
Glucose Oxidase Driven Hydrogen Sulfide-Releasing Nanocascade for Diabetic Infection Treatment.
Topics: Diabetes Mellitus; Glucose; Glucose Oxidase; Humans; Hydrogen Peroxide; Hydrogen Sulfide; Nanopartic | 2023 |
Characterisation of the hydrogen sulfide system in early diabetic kidney disease.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Endothelial Cells; Glucose; Hydrogen Sulfide; Ki | 2023 |
Hydrogen sulfide releasing poly(γ-glutamic acid) biocomposite hydrogel with monitoring, antioxidant, and antibacterial properties for diabetic wound healing.
Topics: Anthocyanins; Anti-Bacterial Agents; Antioxidants; Diabetes Mellitus; Glutamic Acid; Humans; Hydroge | 2023 |
The role of hydrogen sulfide in health and disease.
Topics: Carbon Monoxide; Diabetes Mellitus; Gasotransmitters; Gastrointestinal Diseases; Gene Expression Reg | 2018 |
Selective detection of acetone and hydrogen sulfide for the diagnosis of diabetes and halitosis using SnO(2) nanofibers functionalized with reduced graphene oxide nanosheets.
Topics: Acetone; Diabetes Mellitus; Graphite; Halitosis; Humans; Hydrogen Sulfide; Microscopy, Electron, Sca | 2014 |
Redox regulation of endothelial cell fate.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Cell Cycle; Cell Movement; Cell Transdifferentiation; C | 2014 |
Fast responding exhaled-breath sensors using WO3 hemitubes functionalized by graphene-based electronic sensitizers for diagnosis of diseases.
Topics: Acetone; Biosensing Techniques; Breath Tests; Diabetes Mellitus; Graphite; Halitosis; Humans; Hydrog | 2014 |
Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S Pathway: Functional Impairment by Hyperglycemia and Restoration by DL-α-Lipoic Acid.
Topics: Animals; Cell Line; Cyclic GMP-Dependent Protein Kinases; Cysteine; Diabetes Mellitus; Disease Model | 2015 |
Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics.
Topics: Acetone; Adenine; Biomarkers; Biosensing Techniques; Cardiovascular Diseases; Cytosine; Diabetes Mel | 2016 |
Gasotransmitters in Vascular Complications of Diabetes.
Topics: Biological Availability; Carbon Monoxide; Diabetes Mellitus; Diabetic Angiopathies; Gasotransmitters | 2016 |
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation.
Topics: Active Transport, Cell Nucleus; Animals; Atherosclerosis; Diabetes Mellitus; Female; Glucose; Heme O | 2016 |
The novel mitochondria-targeted hydrogen sulfide (H
Topics: Animals; Cell Line; Diabetes Mellitus; Electron Transport; Endothelial Cells; Endothelium, Vascular; | 2016 |
Hydrogen Sulfide Therapy in Diabetes-Accelerated Atherosclerosis: A Whiff of Success.
Topics: Atherosclerosis; Diabetes Mellitus; Humans; Hydrogen Sulfide | 2016 |
Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats.
Topics: Alkynes; Animals; Blood Glucose; Catalysis; Cystathionine gamma-Lyase; Diabetes Mellitus; Glycine; H | 2009 |
[Study on hydrogen sulfide as a gasotransmitter: from bench to bedside].
Topics: Animals; Apoptosis; Cell Proliferation; Diabetes Mellitus; Gases; Humans; Hydrogen Sulfide; Hyperten | 2008 |
Significance of hydrogen sulfide production in the pancreatic β-cell.
Topics: Animals; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes Mellitus; Humans; Hydrogen | 2011 |
[Production of hydrogen sulfide and its protective role in the pancreatic B-cell].
Topics: Animals; Diabetes Mellitus; Humans; Hydrogen Sulfide; Insulin; Insulin Secretion; Insulin-Secreting | 2012 |
Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy.
Topics: Animals; Calmodulin; Capillaries; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes M | 2013 |
H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells.
Topics: Adenoviridae; Air Pollutants; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cystathionine gam | 2007 |